Glioblastoma Multiforme

Showing 26 - 50 of 372

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

Recruiting
  • Glioblastoma Multiforme
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 30, 2023

Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

Recruiting
  • Astrocytoma, Grades II, III and IV
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)

Active, not recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • Radiation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

Recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • CYNK-001 systemic and Intra cavity administration
  • Duarte, California
  • +5 more
Jan 20, 2023

Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

Completed
  • Glioma
  • +7 more
  • Neural stem cells loaded with an oncolytic adenovirus
  • Duarte, California
  • +1 more
Dec 28, 2022

Glioblastoma Multiforme Trial (5-Aminolevulinic Acid)

Not yet recruiting
  • Glioblastoma Multiforme
  • 5-Aminolevulinic Acid
  • (no location specified)
Jan 16, 2023

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

Recruiting
  • Glioblastoma
  • +3 more
  • Nivolumab-Placebo
  • +4 more
  • Los Angeles, California
  • +3 more
Jan 16, 2023

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Response and Progression in Glioblastoma

Terminated
  • Glioblastoma
  • Glioblastoma Multiforme
  • MRI
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Jan 12, 2023

Glioblastoma Multiforme, Glioma of Brain Trial in Chandler, Phoenix, Scottsdale (Ribociclib, Everolimus)

Completed
  • Glioblastoma Multiforme
  • Glioma of Brain
  • Chandler, Arizona
  • +2 more
Jan 11, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

Recruiting
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +12 more
Jan 9, 2023

Glioblastoma Multiforme, Glioblastoma, Adult, Glioma of Brain Trial in Geneva (IMA950/Poly-ICLC, IMA950/Poly-ICLC and

Active, not recruiting
  • Glioblastoma Multiforme
  • +3 more
  • Geneva, Switzerland
    University Hospitals of Geneva
Dec 23, 2022

NSCLC, Glioblastoma Multiforme Trial in United States (GLR2007)

Completed
  • Non-small Cell Lung Cancer
  • Glioblastoma Multiforme
  • Lafayette, Indiana
  • +3 more
Dec 21, 2022

High Grade Glioma, Glioblastoma Multiforme Trial in Japan, United States (DSP-0390)

Recruiting
  • High Grade Glioma
  • Glioblastoma Multiforme
  • San Francisco, California
  • +8 more
Dec 16, 2022

Primary Glioblastoma, Glioblastoma Multiforme Trial in Worldwide (2-OHOA, TMZ, RT)

Recruiting
  • Primary Glioblastoma
  • Glioblastoma Multiforme
  • Angers, France
  • +19 more
Dec 13, 2022

Multiple Myeloma, DLBCL, Glioblastoma Multiforme Trial in Worldwide (CC-223)

Completed
  • Multiple Myeloma
  • +6 more
  • Los Angeles, California
  • +15 more
Dec 9, 2022

Glioblastoma Multiforme Trial in Baltimore (Retifanlimab, Temozolomide, Radiation Therapy)

Recruiting
  • Glioblastoma Multiforme
  • Baltimore, Maryland
    Johns Hopkins Medical Institution
Dec 5, 2022

Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)

Active, not recruiting
  • Glioma, Malignant
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2022

Glioblastoma Multiforme Trial in Stanford, Baltimore (MBG453)

Active, not recruiting
  • Glioblastoma Multiforme
  • Stanford, California
  • +1 more
Nov 22, 2022

Adult Diffuse Glioma Based on Deep Learning

Recruiting
  • Astrocytoma
  • +2 more
  • multi-parametric magnetic resonance imaging scan
  • Pathology examination
  • Nanjing, Jiangsu, China
    Department of Radiology, the Affiliated Drum Tower Hospital of N
Nov 21, 2022

Glioblastoma Multiforme Trial in United States (ERAS-801)

Recruiting
  • Glioblastoma Multiforme
  • Los Angeles, California
  • +6 more
Nov 14, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)

Recruiting
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • New York, New York
    Lenox Hill Brain Tumor Center
Nov 10, 2022

Glioblastoma Multiforme Trial in Brno (11C-Methionine PET/CT)

Recruiting
  • Glioblastoma Multiforme
  • 11C-Methionine PET/CT
  • Brno, Czech Republic, Czechia
    Masaryk Memorial Cancer Institute
Nov 3, 2022

Glioblastoma Multiforme Trial in Chapel Hill (CAR.B7-H3T cells infusion)

Recruiting
  • Glioblastoma Multiforme
  • CAR.B7-H3T cells infusion
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 25, 2022

Glioblastoma Multiforme Trial in Toronto (Reduced margin adaptive radiotherapy)

Recruiting
  • Glioblastoma Multiforme
  • Reduced margin adaptive radiotherapy
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Oct 19, 2022